SCHEMBL8987066

SCHEMBL8987066

Cc1ccc(-c2cc(-c3ccccc3)[nH]c(=O)c2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.51
RAB9A P51151 3/20 0.51
CTSV O60911 1/20 0.51
CTSL P07711 1/20 0.51
KDM4E B2RXH2 5/20 0.50
MAPT P10636 4/20 0.50
LMNA P02545 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
NPC1 O15118 2/20 0.50
HSD17B10 Q99714 2/20 0.50
TP53 P04637 1/20 0.50
TAS2R38 P59533 1/20 0.50
TNKS2 Q9H2K2 1/20 0.49
GAA P10253 5/20 0.48
ALDH1A1 P00352 4/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C19 P33261 1/20 0.48
HPRT1 P00492 1/20 0.47
NOTUM Q6P988 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8799713 1.00 HPGD (0.51) HPGDRAB9ACTSVCTSLKDM4E
SCHEMBL6756097 0.89 TAS2R38 (0.60) HPGDRAB9ACTSVCTSLKDM4E
SCHEMBL8987272 0.85 NOTUM (0.50) HPGDRAB9AKDM4EMAPTLMNA
SCHEMBL6762114 0.83 CTSV (0.51) HPGDCTSVCTSLKDM4EMAPT
SCHEMBL8987106 0.83 CYP1A2 (0.52) HPGDRAB9AKDM4EMAPTLMNA
SCHEMBL8987311 0.83 CYP1A2 (0.52) HPGDRAB9AKDM4EMAPTLMNA
SCHEMBL19955621 0.83 ALDH1A1 (0.52) HPGDRAB9ACTSVCTSLKDM4E
SCHEMBL8987070 0.83 CTSV (0.51) HPGDCTSVCTSLKDM4EMAPT
SCHEMBL8986985 0.82 KDM4E (0.59) HPGDRAB9AKDM4EMAPTLMNA
SCHEMBL8987420 0.82 MAPT (0.48) RAB9AKDM4EMAPTLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5492915-A ANTIINFLAMMATORY AGENTS RHONE-POULENC RORER S.A. (FR) 1996-02-20 US disclosed
US-5366982-A Antiinflammatory agents or antihistamines RHONE-POULENC RORER S.A. (FR) 1994-11-22 US disclosed
EP-0540604-A1 SUBSTITUTED BICYCLIC BIS-ARYL COMPOUNDS EXHIBITING SELECTIVE LEUKOTRIENE B 4? ANTAGONIST ACTIVITY, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS Aventis Pharma S.A. (FR) 1993-05-12 EP disclosed
WO-1992001675-A2 SUBSTITUTED BICYCLIC BIS-ARYL COMPOUNDS EXHIBITING SELECTIVE LEUKOTRIENE B4 ANTAGONIST ACTIVITY, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS RHONE-POULENC RORER S.A. (FR) 1992-02-06 WO disclosed